Innate Pharma S.A. (IPHA)
$2.21-2.21%Close
BUYRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $208M
- Avg volume
- 142.0K
- Beta
- 0.88
- P/E (TTM)
- -3.41
- Short % float
- 0.22%
- Days to cover
- 27.5
- SI change
- -6.8%
- 1W
- -2.21%
- 1M
- +24.16%
- 3M
- +20.77%
- YTD
- +21.43%
- vs SPY 1W
- -1.02%
- vs SPY 1M
- +20.84%
- vs SPY 3M
- +18.37%
- vs SPY YTD
- +9.67%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 1
- GROWTH
- 8
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-78.4%
GROSS100
OP-2058
NET-1765
[VALUATION]
P/E TTM-3.41
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B-7.91
P/FCF-
EV/EBITDA-3.05
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.27
ND/EBITDA-
BETA0.88
